132 related articles for article (PubMed ID: 35567757)
21. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
Xu HM; Chen Y; Xu J; Zhou Q
World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
[TBL] [Abstract][Full Text] [Related]
22. Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison.
Lei X; Zhang J; Xu Q; Li J; Qian Y; Zhang J; Liu L; Zhong W; Wang Y; Han X; Tang J; Zeng M; Mao Y
J Int Med Res; 2021 Aug; 49(8):3000605211039810. PubMed ID: 34433332
[No Abstract] [Full Text] [Related]
23. [Interventional effect of bicyclol on isoniazid-induced liver injury in rats and the expression of glucose-regulated protein 78, and growth arrest and DNA-damage-inducible gene 153].
Peng XY; Luo XH; Yang Q; Cheng ML; Han B; Xie RJ
Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):133-139. PubMed ID: 30818919
[No Abstract] [Full Text] [Related]
24. [Resolution of racemic anti-hepatitis drug ( +/- ) -bicyclol].
Hu W; Zhang CZ; Li Y
Yao Xue Xue Bao; 2006 Mar; 41(3):221-4. PubMed ID: 16758991
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of bicyclol on acute alcohol-induced liver injury in mice.
Zhao J; Chen H; Li Y
Eur J Pharmacol; 2008 May; 586(1-3):322-31. PubMed ID: 18371952
[TBL] [Abstract][Full Text] [Related]
26. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.
Lammert C; Einarsson S; Saha C; Niklasson A; Bjornsson E; Chalasani N
Hepatology; 2008 Jun; 47(6):2003-9. PubMed ID: 18454504
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial.
Ailani J; Lipton RB; Hutchinson S; Knievel K; Lu K; Butler M; Yu SY; Finnegan M; Severt L; Trugman JM
Headache; 2020 Jan; 60(1):141-152. PubMed ID: 31913519
[TBL] [Abstract][Full Text] [Related]
28. Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease.
Chu NH; Li L; Zhang X; Gu J; Du YD; Cai C; Xiao HP
Int J Tuberc Lung Dis; 2015 Apr; 19(4):475-80. PubMed ID: 25860005
[TBL] [Abstract][Full Text] [Related]
29. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
30. Bicyclol for chronic hepatitis C.
Yang XY; Zhuo Q; Wu TX; Liu GJ
Cochrane Database Syst Rev; 2007 Jan; (1):CD004994. PubMed ID: 17253534
[TBL] [Abstract][Full Text] [Related]
31. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
Asgarshirazi M; Shariat M; Sheikh M
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):296-302. PubMed ID: 28603098
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol.
Li M; Liu GT
World J Gastroenterol; 2004 Jun; 10(12):1775-9. PubMed ID: 15188504
[TBL] [Abstract][Full Text] [Related]
33. Effects of bicyclol on liver regeneration after partial hepatectomy in rats.
Yao XM; Zhao J; Li Y; Li Y
Dig Dis Sci; 2009 Apr; 54(4):774-81. PubMed ID: 19219550
[TBL] [Abstract][Full Text] [Related]
34. Protection by bicyclol derivatives against acetaminophen-induced acute liver failure in mice and its active mechanism.
Hou Y; Li L; Wei H; Wu L; Tong Y; Wu S; Liu G
Liver Int; 2008 Nov; 28(9):1226-35. PubMed ID: 18435715
[TBL] [Abstract][Full Text] [Related]
35. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
36. An analysis of the efficacy and safety of compound glycyrrhizin injections in the treatment of drug-induced liver injury using a nationwide database.
Yao L; Zhang J; Jin J; Li H; Li L; Han X; Raza HK; Li X; Mao Y
Int J Clin Pharm; 2022 Jun; 44(3):731-740. PubMed ID: 35438473
[TBL] [Abstract][Full Text] [Related]
37. Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats.
Liu X; Zhao M; Mi J; Chen H; Sheng L; Li Y
Molecules; 2017 Apr; 22(4):. PubMed ID: 28387740
[TBL] [Abstract][Full Text] [Related]
38. A Randomized Controlled Trial of Intravenous N-Acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury.
Moosa MS; Maartens G; Gunter H; Allie S; Chughlay MF; Setshedi M; Wasserman S; Stead DF; Hickman N; Stewart A; Sonderup M; Spearman CW; Cohen K
Clin Infect Dis; 2021 Nov; 73(9):e3377-e3383. PubMed ID: 32845997
[TBL] [Abstract][Full Text] [Related]
39. Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.
Marcinak JF; Munsaka MS; Watkins PB; Ohira T; Smith N
Drug Saf; 2018 Jun; 41(6):625-640. PubMed ID: 29492878
[TBL] [Abstract][Full Text] [Related]
40. [Comparison on the efficacy and safety of biphenyl dimethyl dicarboxylate and ursodeoxycholic acid in patients with abnormal alanine aminotransferase: multicenter, double-blinded, randomized, active-controlled clinical trial].
Lee SH; Cheon GJ; Kim HS; Kim YD; Kim SG; Kim YS; Jeong SW; Jang JY; Kim BS
Korean J Gastroenterol; 2014 Jul; 64(1):31-9. PubMed ID: 25073669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
